symptom | Page 61 of 64 | Health Newstrack

Stricter warnings for botox, myobloc botulinum injections

Botox and a similar injection Myobloc should come with stronger warnings following reports of 16 deaths after the botulinum toxin spread inside the body, a U.S. consumer group Public Citizen said.
– The Food and Drug Administration (FDA) should immediately increase its warnings and directly warn patients and doctors about the use of botulinum toxin ? available as Botox and Myobloc ? because of serious adverse reactions, including deaths, linked to the drug, Public Citizen said in a petition filed with the FDA.

Mobile phone may interrupt sleep

Scientists studied the effect of using a mobile phone before going to bed and found that those who were exposed to phone radiation took longer to reach the deep sleep. – Radiation from mobile phones delays and reduces sleep, and causes headaches and confusion, according to a new study funded by handset manufacturers. The study was published in the peer-reviewed scientific journal: Progress In Electromagnetics Research Symposium (PIERS) Online.

Gene therapy promising for chronic pain relief

Researchers in the Department of Medicine and Department of Neurosciences at Mount Sinai School of Medicine have discovered that chronic pain can be successfully treated with novel targeted gene therapy. – Now, chronic pain can be successfully treated with novel targeted gene therapy. In an effort to find a more effective treatment for chronic pain, researchers at Mount Sinai developed a gene therapy technique that simulates the pain-killing effect of opiate drugs.

Caffeine during pregnancy increases miscarriage risk

If you are pregnant and need caffeine to get you going, try keeping it to one cup or less a day. Avoiding it may be even better. – High doses of daily caffeine during pregnancy ? whether from coffee, tea, caffeinated soda or hot chocolate ? cause an increased risk of miscarriage, according a new study by the Kaiser Permanente Division of Research. The study controlled, for the first time, pregnancy-related symptoms of nausea, vomiting and caffeine aversion that tended to interfere with the determination of caffeine’s true effect on miscarriage risk.

Prodesse’s ProFlu+ Test for Respiratory Viruses receives FDA clearance

Prodesse’s ProFlu+ Test for Respiratory Viruses receives FDA clearance for Marketing Real-Time Test, detects four viruses, including influenza; results available in about 3 hours. – Prodesse, Inc., the leader in multiplex real-time PCR for infectious disease, announced that it received clearance from the U.S. Food and Drug Administration (FDA) to market its ProFlu+? Assay.

Pfizer updated CHANTIX label to quit smoking with more warnings

Pfizer’s CHANTIX label in the U.S. to include a warning for neuropsychiatric symptoms, including changes in behavior, agitation, depressed mood, suicidal ideation and suicidal behavior. – Cigarette smoking is associated with significant morbidity and mortality. Smoking is the leading preventable cause of disease and premature death in the United States, with more than 438,000 U.S. deaths annually attributable to smoking. Patients who smoke cigarettes should be counseled to quit. CHANTIX was approved in May of 2006 in the U.S. as an aid to smoking cessation.

GVAX cancer immunotherapy improves prostate cancer survival

Interim analysis supports continuation of Cell Genesys’ VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer – Cell Genesys, Inc. (Nasdaq: CEGE) announced that the Independent Data Monitoring Committee (IDMC) for VITAL-1, the first of two ongoing Phase 3 clinical trials of GVAX immunotherapy for prostate cancer, has completed a pre-planned interim analysis and has recommended that the study continue, as GVAX cancer immunotherapy improves prostate cancer patients survival.

Sickle cell disease pain occurs daily

In adults with sickle cell disease, pain can occur daily and is much more severe than previously believed. – Sickle cell disease pain can occur daily, and is far more prevalent and severe than previous large studies have indicated. Patients are at home mostly struggling with their pain rather than coming into the hospital or emergency department.

Use OTC cough and cold products with care

US FDA strongly recommends that over-the-counter (OTC) cough and cold products should not be used for infants and children under 2 years of age because serious and potentially life-threatening side effects could occur. – US health agency FDA is recommending that over-the-counter (OTC) cough and cold products should not be used to treat infants and children less than 2 years of age because serious and potentially life-threatening side effects can occur from such use. OTC cough and cold products include decongestants, expectorants, antihistamines, and antitussives (cough suppressants) for the treatment of colds.

Enbrel, etanercept improved psoriasis in children and adolescents

Etanercept (Enbrel) significantly reduces psoriasis disease severity in children and adolescents with moderate-to-severe plaque psoriasis. – A Phase 3 study showed that children and adolescents with moderate to severe plaque psoriasis who received treatment with Enbrel experienced significant improvements in the signs and symptoms of their disease psoriasis.